Moore Capital Management’s Pulmonx LUNG Stock Holding History

Moore Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,152	Closed	-$419K	–	599
2022 Q3	$419K	Sell	25,152 -27,577	-52%	-$508K	0.01%	438
2022 Q2	$776K	Sell	52,729 -97,506	-65%	-$2.01M	0.02%	423
2022 Q1	$3.73M	Sell	150,235 -71,515	-32%	-$1.85M	0.09%	265
2021 Q4	$7.11M	Sell	221,750 -56,212	-20%	-$2.05M	0.14%	157
2021 Q3	$10M	Buy	277,962 +169,557	+156%	+$6.67M	0.15%	125
2021 Q2	$4.78M	Buy	108,405 +60,395	+126%	+$2.63M	0.07%	300
2021 Q1	$2.2M	Sell	48,010 -41,275	-46%	-$2.37M	0.03%	433
2020 Q4	$6.16M	Buy	+89,285	New	+$4.37M	0.07%	200

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Moore Capital Management's LUNG Position: Q4 2022 in Review

Moore Capital Management sold out of Pulmonx (LUNG) in Q4 2022, closing a stake of 25,152 shares — an estimated $419K sold.

Moore Capital Management first reported a position in LUNG in Q4 2020 and held it in 8 quarters. The position peaked at $10M in Q3 2021. 116 funds tracked by Wall St. Rank hold LUNG as of Q4 2022.

Moore Capital Management reported no remaining Pulmonx position as of Q4 2022 after selling out during the quarter.
Moore Capital Management sold 25,152 Pulmonx shares in Q4 2022, an estimated $419K.
Moore Capital Management first reported a position in Pulmonx in Q4 2020 and held it in 8 quarters.
Moore Capital Management's Pulmonx position peaked at $10M in Q3 2021.
116 funds tracked by Wall St. Rank held Pulmonx as of Q4 2022.

Based on Moore Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.